Related Experiment Videos
Increased rhodamine 123 uptake by carcinoma cells
Cancer Research
|December 1, 1985
Summary
Carcinoma cells accumulate the fluorescent dye rhodamine 123 (Rh-123) differently than normal cells, suggesting potential for targeted cancer chemotherapy. This difference in dye uptake highlights distinct mitochondrial characteristics in cancer cells.
Area of Science:
- Cell Biology
- Biochemistry
- Cancer Research
Background:
- Mitochondria are crucial organelles involved in cellular energy production and signaling.
- Mitochondrial function and morphology can be altered in cancer cells.
- Rhodamine 123 (Rh-123) is a fluorescent dye that accumulates in active mitochondria.
Purpose of the Study:
- To investigate the differential uptake and localization of rhodamine 123 (Rh-123) in various cell lines, including carcinoma-derived cells.
- To compare Rh-123 accumulation patterns with mitochondrial morphology and membrane potential.
- To explore the potential of Rh-123 uptake as a marker for cancer cell characteristics and a target for chemotherapy.
Main Methods:
- Quantification of total cellular Rh-123 content using butanol extraction.
- Fluorescence microscopy to observe Rh-123 localization and mitochondrial morphology.
- Incubation of cells with Rh-123 at varying concentrations and exposure times.
- Treatment with a mitochondrial membrane potential inhibitor (p-trifluoromethoxyphenylhydrazone) to assess its effect on Rh-123 uptake.
Main Results:
- Two distinct categories of cell types emerged based on Rh-123 uptake: progressive accumulators (e.g., carcinoma lines) and early equilibrators with minimal uptake (e.g., normal epithelial lines).
- Progressive Rh-123 accumulation correlated with dye concentration and exposure time, reaching apparent saturation in high-uptake cells.
- Fluorescence microscopy revealed mitochondrial-specific Rh-123 localization initially, with subsequent alterations in mitochondrial morphology and cytoplasmic fluorescence observed in high-uptake (carcinoma) cells.
- Inhibition of mitochondrial membrane potential significantly reduced Rh-123 uptake in high-uptake cells.
Conclusions:
- Carcinoma-derived cell lines exhibit a distinct pattern of progressive rhodamine 123 accumulation compared to normal cell lines.
- These differences in Rh-123 uptake and associated mitochondrial changes may be transformation-related characteristics.
- The mechanism of progressive Rh-123 accumulation in carcinoma cells presents a potential target for developing novel chemotherapeutic strategies against certain carcinomas.